526 related articles for article (PubMed ID: 9697699)
1. A retinoblastoma-binding protein that affects cell-cycle control and confers transforming ability.
Woitach JT; Zhang M; Niu CH; Thorgeirsson SS
Nat Genet; 1998 Aug; 19(4):371-4. PubMed ID: 9697699
[TBL] [Abstract][Full Text] [Related]
2. E2F4-RB and E2F4-p107 complexes suppress gene expression by transforming growth factor beta through E2F binding sites.
Li JM; Hu PP; Shen X; Yu Y; Wang XF
Proc Natl Acad Sci U S A; 1997 May; 94(10):4948-53. PubMed ID: 9144170
[TBL] [Abstract][Full Text] [Related]
3. The retinoblastoma gene product inhibits TGF-beta1 induced apoptosis in primary rat hepatocytes and human HuH-7 hepatoma cells.
Fan G; Ma X; Kren BT; Steer CJ
Oncogene; 1996 May; 12(9):1909-19. PubMed ID: 8649852
[TBL] [Abstract][Full Text] [Related]
4. Activation of a retinoblastoma-protein-dependent pathway by sphingosine.
Dbaibo GS; Wolff RA; Obeid LM; Hannun YA
Biochem J; 1995 Sep; 310 ( Pt 2)(Pt 2):453-9. PubMed ID: 7654183
[TBL] [Abstract][Full Text] [Related]
5. E2F-Rb complexes assemble and inhibit cdc25A transcription in cervical carcinoma cells following repression of human papillomavirus oncogene expression.
Wu L; Goodwin EC; Naeger LK; Vigo E; Galaktionov K; Helin K; DiMaio D
Mol Cell Biol; 2000 Oct; 20(19):7059-67. PubMed ID: 10982822
[TBL] [Abstract][Full Text] [Related]
6. RB and hbrm cooperate to repress the activation functions of E2F1.
Trouche D; Le Chalony C; Muchardt C; Yaniv M; Kouzarides T
Proc Natl Acad Sci U S A; 1997 Oct; 94(21):11268-73. PubMed ID: 9326598
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-beta regulation of retinoblastoma gene product and E2F transcription factor during cell cycle progression in mouse fibroblasts.
Kim TA; Ravitz MJ; Wenner CE
J Cell Physiol; 1994 Jul; 160(1):1-9. PubMed ID: 8021288
[TBL] [Abstract][Full Text] [Related]
8. p120-v-Abl expression overcomes TGF-beta1 negative regulation of c-myc transcription but not cell growth.
Birchenall-Roberts MC; Kim SJ; Bertolette DC; Turley JM; Fu T; Bang OS; Kasper JJ; Yoo YD; Ruscetti FW
Oncogene; 1996 Oct; 13(7):1499-509. PubMed ID: 8875988
[TBL] [Abstract][Full Text] [Related]
9. Expression of the E2F1 transcription factor overcomes type beta transforming growth factor-mediated growth suppression.
Schwarz JK; Bassing CH; Kovesdi I; Datto MB; Blazing M; George S; Wang XF; Nevins JR
Proc Natl Acad Sci U S A; 1995 Jan; 92(2):483-7. PubMed ID: 7831315
[TBL] [Abstract][Full Text] [Related]
10. Transient accumulation of retinoblastoma/E2F-1 protein complexes correlates with the onset of neuronal differentiation in the developing quail neural retina.
Kastner A; Espanel X; Brun G
Cell Growth Differ; 1998 Oct; 9(10):857-67. PubMed ID: 9790497
[TBL] [Abstract][Full Text] [Related]
11. The transcription factor E2F-1 modulates TGF-beta1 RNA expression in glial cells.
Thatikunta P; Raj GV; Kundu M; Khalili K; Amini S
Oncogene; 1997 Jun; 14(24):2959-69. PubMed ID: 9205103
[TBL] [Abstract][Full Text] [Related]
12. The cloning of plant E2F, a retinoblastoma-binding protein, reveals unique and conserved features with animal G(1)/S regulators.
RamÃrez-Parra E; Xie Q; Boniotti MB; Gutierrez C
Nucleic Acids Res; 1999 Sep; 27(17):3527-33. PubMed ID: 10446243
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor beta inhibits the phosphorylation of pRB at multiple serine/threonine sites and differentially regulates the formation of pRB family-E2F complexes in human myeloid leukemia cells.
Hu X; Cress WD; Zhong Q; Zuckerman KS
Biochem Biophys Res Commun; 2000 Oct; 276(3):930-9. PubMed ID: 11027571
[TBL] [Abstract][Full Text] [Related]
14. Retinoblastoma-repression of E2F-dependent transcription depends on the ability of the retinoblastoma protein to interact with E2F and is abrogated by the adenovirus E1A oncoprotein.
Arroyo M; Raychaudhuri P
Nucleic Acids Res; 1992 Nov; 20(22):5947-54. PubMed ID: 1461728
[TBL] [Abstract][Full Text] [Related]
15. Disruption of RB/E2F-1 interaction by single point mutations in E2F-1 enhances S-phase entry and apoptosis.
Shan B; Durfee T; Lee WH
Proc Natl Acad Sci U S A; 1996 Jan; 93(2):679-84. PubMed ID: 8570615
[TBL] [Abstract][Full Text] [Related]
16. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
Santoni-Rugiu E; Jensen MR; Thorgeirsson SS
Cancer Res; 1998 Jan; 58(1):123-34. PubMed ID: 9426068
[TBL] [Abstract][Full Text] [Related]
17. Release of cell cycle constraints in mouse melanocytes by overexpressed mutant E2F1E132, but not by deletion of p16INK4A or p21WAF1/CIP1.
Halaban R; Cheng E; Zhang Y; Mandigo CE; Miglarese MR
Oncogene; 1998 May; 16(19):2489-501. PubMed ID: 9627115
[TBL] [Abstract][Full Text] [Related]
18. A genetic analysis of the E2F1 gene distinguishes regulation by Rb, p107, and adenovirus E4.
Cress WD; Johnson DG; Nevins JR
Mol Cell Biol; 1993 Oct; 13(10):6314-25. PubMed ID: 8413230
[TBL] [Abstract][Full Text] [Related]
19. Differential specificity for binding of retinoblastoma binding protein 2 to RB, p107, and TATA-binding protein.
Kim YW; Otterson GA; Kratzke RA; Coxon AB; Kaye FJ
Mol Cell Biol; 1994 Nov; 14(11):7256-64. PubMed ID: 7935440
[TBL] [Abstract][Full Text] [Related]
20. Growth suppression by an E2F-binding-defective retinoblastoma protein (RB): contribution from the RB C pocket.
Whitaker LL; Su H; Baskaran R; Knudsen ES; Wang JY
Mol Cell Biol; 1998 Jul; 18(7):4032-42. PubMed ID: 9632788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
